2024 Marks Record Performance by Viasonix
Over the past 15 years, Viasonix consistently showed a continuous year-by-year increase in sales. Viasonix medical device sales in 2024, however, leaped dramatically forward compared to previous years, with over 25% increase in sales relative to the previous sales record year, marking yet another significant milestone for the company.
What makes this achievement even more remarkable is that it was reached before obtaining CE and FDA approvals for the newly released Falcon/Xpress system. These approvals were granted in Q4 of 2024, paving the way for even greater expansion in 2025.
Viasonix has been very stable and profitable, year in and year out, for the past 15 years. The exciting performance of 2024 definitely lifts Viasonix to the next level.
Industry-Leading Product Lines
- Falcon Vascular Diagnostic Systems – Primarily used in vascular, cardiovascular, angiology, and phlebology
- Dolphin TCD Machines – Serving neurology, neurosurgery, cardiovascular, anesthesia, physiology, and stroke center
- LiteWalk Foot Compression Device – Designed for homecare use, offering a non-invasive solution for improving circulation.
A Promising Future for Viasonix
Viasonix remains committed to continuous innovation, enhancing its existing product lines, and developing new breakthrough solutions that address specific market needs.
The financial success of 2024 was achieved solely with Viasonix’s current product lineup. However, 2025 is already set to be another milestone year with the introduction of additional products and further commercialization of the LiteWalk foot compression device.
The new Falcon/Xpress model, launched earlier this year in the USA and numerous international markets, is expected to become a significant market changer in the vascular arena. Additionally, Viasonix’s R&D team is in the final stages of developing several groundbreaking medical devices that will reshape targeted market segments. These innovations are expected to launch later this year, further driving company revenue and profitability.
The growth of Viasonix has been continuous since its inception a couple of decades ago, and with the exciting 2024 performance and the thrilling expectations with the new products, the future looks brighter than ever!
Stay Connected
For more information about Viasonix’s products and future innovations, feel free to leave us a message.
